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Summary 
 
Background 
Little is known about the historic and current risk of Zika virus (ZIKV) infection in Southeast Asia, 
where the mosquito vector is widespread and other arboviruses circulate endemically. The aim 
of the study is to explore the long-term circulation of ZIKV in Thailand. 
 
Methods 
Centralized ZIKV surveillance began in Thailand in January 2016. Between January 2016 and 
December 2017, suspected Zika cases had biological samples (serum, plasma, urine) tested for 
confirmation through PCR. We analyzed the spatial and age distribution of cases. We 
constructed time-resolved phylogenetic trees using genomes from Thailand and elsewhere to 
estimate when ZIKV was first introduced.  
 
Findings 
There were 368 confirmed cases out of 1,717 symptomatic individuals tested. Cases came from 
throughout the year and from 29 of the 76 Thai provinces. Individuals had 2.8 (95%CI: 2.3-3.6) 
times the odds of testing positive if they came from the same district and were sick within the 
same year of a confirmed case relative to the odds of testing positive anywhere, consistent with 
focal transmission. The probability of cases being <10y was 0.99 (95%CI: 0.72-1.30) times the 
probability of being that age in the underlying population. This rose to 1.62 (95%CI 1.33-1.92) 
among 21-30y and fell to 0.53 (95%CI: 0.40-0.66) for those >50y. This age distribution is 
consistent with that observed in the ZIKV epidemic in Colombia. Phylogenetic reconstructions 
suggest persistent circulation within Thailand since at least 2002. 
 
Interpretation 
We find evidence that ZIKV has circulated at a low but sustained level for at least 16 years, 
suggesting that ZIKV can adapt to persistent endemic transmission. Health systems need to 
adapt to cope with regular occurrences of the severe complications associated with infection.  
 
Funding 
NSF, NIH  
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Research in context  
 
Evidence before this study  
To assess the evidence-base of Zika in Thailand, we searched Google Scholar for all 
publications prior to September 2018 that had the words “Zika” and “Thailand” in the title. We 
found 25 documents, mostly consisting of individual case reports. Two articles showed that 
cases of Zika had been found in different places in Thailand, however, no previous studies have 
considered the endemicity of the virus in the country and the likely level of underlying immunity. 
An equivalent search in PubMed yielded 12 results with no additional documents. 
 
Added value of this study  
Using data from the national surveillance system, we present a comprehensive assessment of 
the Zika situation in Thailand. We use information from symptomatic individuals that tested 
negative for Zika to control for underlying spatial differences in healthcare seeking. We 
demonstrate that the age distribution of Zika cases are largely consistent with that from a known 
emergent setting (Colombia) and different from dengue, where population immunity is high. We 
use time-resolved phylogenetic approaches to demonstrate that ZIKV has circulated in the 
country for 17 years if not longer.  
 
Implications of all the available evidence  
Our findings are consistent with sustained transmission of ZIKV within a single country for many 
years. This suggests that other countries that have also experienced ZIKV outbreaks may also 
be affected by the virus in future years. Our findings support the need for the deployment of 
long-term sustainable surveillance and intervention strategies. 
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Introduction 
 
Zika virus (ZIKV) is a flavivirus spread by Aedes mosquitoes that was first discovered in Uganda 
in 1947 with the first reported presence in Asia in 1966 in Malaysia1,2. Infection in humans 
usually causes mild disease or no symptoms at all3. However, ZIKV infection has been shown to 
be associated with the development of Guillain Barré Syndrome and infection during the early 
stages of pregnancy has been linked to Congential Microcephaly Syndrome4,5. Much of the 
current interest in ZIKV has been focused on South America, where the virus spread widely 
following its introduction in 20136. The situation in Asia is much less clear.  
 
It has been proposed that ZIKV has circulated silently in the region for years, as has previously 
been shown with another arbovirus, chikungunya virus7,8. The poor current understanding of the 
long-term transmission patterns of ZIKV is not surprising. Even when symptoms do occur, 
laboratory testing for ZIKV is rarely performed and clinical misdiagnosis is common, especially 
given the potential for serological cross-reactivity with dengue virus (DENV) which has 
circulated endemically in much of Southeast Asia for decades9. In support of sustained 
transmission are a handful of viral isolates obtained in the 1960s in Malaysia, from 2006 in 
Thailand and from 2012 in the Philippines, all prior to the emergence of the Asian lineage into 
South America6,10–12. Seroprevalence studies in the 1950s also showed some population 
immunity to ZIKV, however, interpreting the results of serology is complicated due to flavivirus 
cross-reactivity3,13. By contrast, the viruses responsible for a recent outbreak in Singapore 
showed little viral diversity, consistent with recent emergence, however, they were genetically 
closest to viruses isolated from other Asian countries than to South American strains consistent 
with an introduction from the surrounding region14.  
 
It is still unknown if there has been widespread long-term circulation of ZIKV in the region, 
resulting in high levels of population immunity. The epidemic versus endemic nature of ZIKV 
has important consequences for tackling the pathogen and in particular the risk of severe 
complications. It has been suggested that ZIKV epidemics are likely to burn themselves out 
after just a few years, with resulting population immunity leading to absence of the virus for 
decades15. In such a scenario, efforts to contain the virus and enhanced surveillance for Guillain 
Barré Syndrome and microcephaly may not be an effective use of resources, given the lead 
time and logistical constraints in establishing such measures. By contrast, if ZIKV can transition 
to sustained endemic circulation, this necessitates the development of long-term intervention 
strategies and the establishment of systematic surveillance for the severe complications 
associated with infection. 
 
Analyzing the ZIKV situation in Thailand provides an opportunity to understand the long-term 
epidemic potential of ZIKV. Aedes mosquitoes are found throughout Thailand and all four 
serotypes of DENV, which is transmitted by the same mosquitoes, circulate endemically 
throughout the year9,16. Thailand has been identified by phylogenetic studies as a potential 
source of DENV in the region17. Following the renewed interest in ZIKV globally, in 2016 the 
National Institute of Health in Thailand, starting the centralized testing of serum, plasma and 
urine samples of individuals with symptoms consistent with Zika from throughout the country. 
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Here, we present the results of this surveillance. In addition, we use the age distribution of 
cases to infer the immunity to ZIKV in the population and use phylogenetic analyses to infer the 
current diversity in circulating viruses. 
 
 
Methods 
 
Data collection 
 
From January 2016, the National Institute of Health in Thailand established the centralized 
testing of suspected Zika cases that presented at hospitals from throughout the country. The 
symptoms of suspected cases were presence of maculopapular rash and a fever, or just a rash 
in provinces where Zika cases had already been identified. Acute serum, plasma or urine 
samples of suspected cases were sent to the National Institute of Health laboratories in 
Bangkok where they were tested for evidence of infection using PCR. The date of symptom 
onset, the date of testing, the district of the hospital, the age of the individual and the results of 
the testing were recorded. 
 
Phylogenetic analyses 
 
In order to assess whether the recent cases of Zika in Thailand represent a re-emergence of 
ZIKV associated with the large outbreak in South America or sustained transmission within 
Thailand, we downloaded all available full genome sequences from Thailand (N=8) from 
GenBank. We also selected a random sample of other sequences from Asia (Cambodia (N=3), 
Singapore (N=3), Malaysia (N=2)) as well as sequences from French Polynesia (N=5), Brazil 
(N=9) and Colombia (N=5). We used these sequences to build time-resolved phylogenetic trees 
using BEAST software with a GTR+G nucleotide substitution model and a random local clock, 
as has previously been identified as optimal for ZIKV phylogenetic analyses14,23.  
 
To estimate the date that ZIKV first emerged in Thailand, we randomly selected 100 time-
resolved trees from the posterior distribution. For each tree, we extracted the date for the most 
ancient (i.e., furthest back in time) Most Recent Common Ancestor (MRCA) separating any two 
Thai viruses. We then calculated the mean date and 95% confidence intervals across the 100 
trees. 
  
To assess the diversity in viruses within any location over time, we randomly selected 100 trees 
from the posterior distribution. For each tree we extracted the evolutionary distance separating 
each pair of tips. For all pairs of viruses coming from the same country and isolated within a 
year of each other, we calculated the proportion that had an MRCA within different time limits 
going back in time, ranging from 0.1 years to 10 years in the past. We then calculated the mean 
proportion over the 100 trees.  
 
The GenBank accession numbers for the sequences used in these analyses can be found in 
Table S1. 
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Statistical analysis 
 
Age distribution analysis 
We can use the age distribution of cases to gain insight into the level of population immunity. If 
ZIKV had circulated endemically for decades, cases would be concentrated in children as most 
adults would be immune from previous infection. By contrast, a novel emergence would result in 
the case distribution being similar to the age distribution of the population. This assumes that 
there are no large-scale differences by age in the probability of becoming infected, developing 
symptoms or seeking care. We used data on the age distribution in Thailand and compared that 
to the age distribution in Zika cases18. As a comparison we also compared the age distribution 
of dengue cases that were also sent to the laboratory between 2011-2016. For each virus, we 
calculate the proportion of cases that were within each ten-year age bin and divided it by the 
proportion of the underlying population within that age bin. Values of this relative proportion of 1 
indicate that individuals in that age category had a similar risk of becoming a case as anyone 
from the population, consistent with no immunity in the population. Relative proportions greater 
than 1 in younger individuals and less than 1 in older individuals are consistent with immunity in 
the population shifting cases to younger individuals19. To assess uncertainty, we used a 
bootstrap approach. We repeatedly randomly resampled all the cases with replacement and 
recalculated the relative proportion each time. Ninety-five percent confidence intervals were 
obtained from the 2.5 and 97.5 percentile of the resultant distribution. To allow us to compare 
the age distribution to ZIKV in a known emergent setting, we calculate the same value for Zika 
cases from Colombia between 2015 and 201620. 
 
Spatial analyses 
The probability that an individual with Zika symptoms presents to healthcare facilities and the 
subsequent probability that healthcare facilities send the samples to be tested by the National 
Institute of Health is likely to differ spatially and temporally. In order to assess whether Zika 
cases persisted in the same district for many months allowing for spatial and temporal biases in 
observation, we used the spatial distribution of both the cases and those that tested negative. 
This test-negative approach assumes that the individuals that tested negative are similar in their 
healthcare seeking as the cases21. To increase the probability that test-negative individuals 
were true negatives, we only included individuals who provided biological samples within seven 
days of symptom onset.  
 
To characterize the spatial dependence among these cases, we calculated the odds of an 
individual with symptoms within 30 days of an index Zika case that lived within the same district 
testing positive for ZIKV relative to the odds of anyone testing positive for ZIKV within that time 
frame. We repeated the analysis considering cases that lived in nearby districts (defined as 
other districts within 50km) and those that lived in distal districts (districts >50km). We then 
considered longer time periods (1- 6 months, 6-12 months and >12 months). This approach has 
previously been used to characterize the spatial and temporal dependence among dengue 
cases22. To assess uncertainty, we used a bootstrap approach where all the cases were 
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resampled with replacement and the odds ratio recalculated. Ninety-five percent confidence 
intervals were obtained from the 2.5 and 97.5 percentiles of the resultant distribution. 
 
To assess whether particular regions had a greater risk of ZIKV than others, we divided the 
country into 6 regions (North, Northeast, Central, South, West and East) and identified the 
region for each symptomatic individual. We then calculated the odds of testing positive among 
individuals within each region, relative to the odds of anyone testing positive. Values greater 
than 1 indicate a greater risk of observing a case in that region compared to the country as a 
whole whereas values less than 1 indicates a reduced risk.  
 
Ethical approval 
 
This study is based on secondary analysis of data collected as part of Thai governmental 
surveillance activities during the global Zika emergency. No ethical approval was required 
because the data were anonymized. 
 
Role of the funding source 
 
The sponsor of the study had no role in study design, data collection, data analysis, data 
interpretation, or writing of the report. The corresponding author had full access to all the data in 
the study and had final responsibility for the decision to submit for publication. 
 
 
Results 
 
Between January 2016 and December 2017, there were 3,089 samples tested from 1,717 
symptomatic individuals for evidence of ZIKV infection. Overall, 21.4% (368/1,717) of individuals 
tested positive (Figure 1A). There were 1,247 serum/plasma samples (181 positive, 14.5%), 
1,831 urine samples (413 positive, 22.5%) and 10 samples from other sources (saliva, CSF with 
none positive) received, with some patients providing multiple samples. The probability of 
testing positive fell from 17.1% (150/879) for serum/plasma samples collected <7 days of 
symptom onset to 7.4% (21/283) in samples collected with longer delays (Figure 1). With urine 
samples, 27.7% (281/1,015) were positive when collected <7 days compared to 17.1% ( 
111/650) with longer delays. Cases were found throughout the year, although with greater 
concentration in the second half of the year with 72% (265/368) of cases occurring between July 
and December. The probability of symptomatic individuals testing positive was consistent in the 
two years (20.4% [257/1258] in 2016 vs 24.2% [111/459] in 2017, p-value 0.1). While 61% 
(224/368) of confirmed Zika cases were female, once we accounted for the probability of being 
tested (62% [1038/1666] of symptomatic individuals sent for testing were female), we observed 
no difference in the odds ratio of testing positive by sex (OR: 1.0, 95%CI: 0.8-1.3).  
 
Samples from individuals with symptoms consistent with ZIKV infection were sent from 60 of the 
76 provinces in Thailand. Twenty-nine of these provinces (48%), and 77 different districts, 
covering all regions in the country, had at least one case, consistent with a widespread 
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distribution of the virus (Figure 1B). We observed a small increased risk of a symptomatic 
individual testing positive for ZIKV in the Northeast (Relative Risk: 1.5, 95%CI: 1.2-1.8) and East 
(Relative Risk: 1.6, 95%CI: 1.2-2.2) relative to the country as a whole and a reduced risk in the 
South (Relative Risk: 0.3, 95%CI: 0.03-0.9) (Figure S1). There were 53 confirmed Zika cases 
from Bangkok, located within the Central region, out of 223 symptomatic individuals tested, with 
the probability of individuals from the capital testing positive being the same as the country as a 
whole (Relative Risk: 1.1, 95%CI: 0.8-1.4).  
 
Within a district we observed strong spatial dependence between cases. Symptomatic 
individuals had 2.8 (95%CI: 2.3-3.6) times the odds of testing positive for ZIKV if they came 
from the same district and were sick within the same year of a confirmed Zika case relative to 
the odds of any symptomatic individual testing positive in that time interval (Figure 2A). This 
value fell to 0.9 (95%CI: 0.2-1.8) at time intervals greater than a year. This spatial dependence 
extended to neighbouring districts too at a reduced scale (Figure 2B).  
 
The mean age of cases was 32y, slightly lower than the mean age of the population (37y). 
Among Zika cases, the probability of being <10 years old, was 0.99 (95%CI: 0.72-1.30) times 
the probability of being within that age range in the underlying population (Figure 3A). This rose 
to 1.62 (95%CI 1.33-1.92) among 21-30 year olds and fell to 0.53 (95%CI: 0.40-0.66) for those 
>50 years. As females of reproductive age may be more likely to seek care due to microcephaly 
risks, we repeated the analysis using males only, finding consistent results. They were also 
largely consistent with the age distribution of cases in Colombia, where the relative risk of being 
a Zika case was lowest in those <10 years (RR: 0.63) and those >50y (RR:0.70) and highest in 
those 21-30 (RR: 1.58) with broadly similar patterns between females and males (Figure 3B). 
The mean age of cases in Colombia was 31y, similar to the mean age in the population (30y). 
As a comparison, dengue cases in Thailand were strongly concentrated in children with a mean 
age of 12y (Figure 3C). The probability of a dengue case being <10 years old was 4.01 (95%CI: 
3.85-4.24) times greater than the probability of being in that age range in the underlying 
population. Dengue cases were 0.04 (0.01-0.05) times as likely to be >50 years than the 
underlying population.  
 
Using time-resolved phylogenetic trees we found that the Thai sequences were ancestral to the 
viral strains from French Polynesia, Brazil and Colombia (Figure 4A). Among these sequences, 
we estimate the emergence of ZIKV occurred in October 2002 (95%CI: January 2001-April 
2004). We also find that the viruses were a lot more diverse in Thailand than in these other 
locations. In Brazil, if we only considered pairs of viruses isolated within a year of each other, 
we found that 88% had an ancestor in common within the within the prior two years (Figure 4B). 
We found similar values for Colombia and French Polynesia. By contrast, no viral pairs from 
Thailand that came from individuals sick within a year of each other had an ancestor in common 
within the prior 2 years. It is only when we considered ancestors in the prior 8 years that this 
value rose to 73%. 
 
 
Discussion 
 9 
 
Here we have presented the results of ZIKV surveillance in Thailand. We demonstrate that 
within the first few months of surveillance being initiated, ZIKV was found throughout the 
country. In individual locations, cases exhibited strong spatial dependence, lasting for at least 
one year. These findings are consistent with sustained focal transmission with occasional longer 
distance transmission events, as has previously shown with DENV24. These findings are also 
consistent with sporadic case reports between 2012-2014 of ZIKV infection occurring in 
locations throughout the country10. Further, while we could not definitely identify the time point in 
which it first entered into the country, it appears to have circulated since at least 2002, many 
years prior to the commencement of surveillance. However, this long-term circulation has not 
yet been enough to result in sufficient immunity to shift transmission to the youngest members 
of the population, as has occurred with DENV. 
 
Where viruses shift from epidemic to endemic transmission, there is a resultant increase in the 
genetic diversity among circulating lineages as individual lineages establish sustained 
transmission chains. For example, with DENV, which has circulated endemically in Thailand for 
decades, it has been previously shown that fewer than 1% of pairs of viruses infected in 
Bangkok at around the same time by the same serotype have a common ancestor within the 
prior 6 months24. Our findings suggest that ZIKV, in Thailand at least, has shifted towards 
endemic circulation. It remains unclear whether ZIKV can also make the transition in South 
America, as DENV did in the 1990s25. 
 
The hypothesis that ZIKV transmission would burn itself out is based on assumptions that large-
scale population immunity will drive the disease to extinction15. Serosurveys conducted after the 
2015-2016 outbreak in South America have found high seroprevalence and are therefore 
consistent with this hypothesis26,27. While serosurveys will be ultimately necessary to properly 
quantify the level of population immunity in Thailand, the observed similarity between the age-
specific incidence patterns in Thailand as compared to those in Colombia and Puerto Rico, 
where ZIKV has only recently emerged, suggest limited population immunity20,28. Thus, our 
findings from Thailand suggest that ZIKV may have found a middle ground - sufficient 
transmission to maintain itself but not at high enough levels to result in widespread immunity. 
Understanding why ZIKV exhibits such different transmission dynamics in Thailand as 
compared to the Americas will require additional studies.  
 
Our findings are also consistent with age-specific differences in symptomatic infection risk or 
health seeking behavior. We find a reduced risk of being a Zika case among those over 50 
years in age and an increased risk in those 21 to 30 years. Similar patterns have been 
described in the American outbreak20,28.  
 
Our findings highlight the key insight that phylogenetic approaches provide, even with just a 
handful of sequences. While we cannot definitely rule out that the individual sequences 
represent the recent offspring from independent introductions into the country, this would 
necessitate a diverse viral reservoir in the wider region, which has not been observed. This is 
also inconsistent with the spatially widespread nature of sporadic case reports within Thailand, 
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prior to surveillance initiation10. Our study also demonstrates the key sensitivity of phylogenetic 
analyses to the underlying sampling of isolates. Using all available sequences from Thailand 
provides an estimate of the most common recent ancestor in the country around 2002. 
However, this is largely reliant on a single isolate from 200612. Had this isolate not been present, 
this estimate would have shifted to 2006 (this would still provide an estimate of 13 years of 
circulation prior to today). It seems likely that additional sampling would shift the estimated date 
of emergence further back, although this may not be possible if the offspring of older lineages 
are now extinct.  
 
Our findings have implications for the ongoing surveillance of ZIKV-related severe health 
complications. Between January 2016 and August 2018, there were four cases of Guillain Barré 
Syndrome in individuals with PCR confirmed ZIKV infection in Thailand29. Over the same period, 
130 pregnant women were identified with ZIKV infection, of which two had subsequent abortions 
due to fetal ZIKV infection. A further 119 of these women have since given birth, four of which to 
babies with microcephaly, although none had signs of fetal ZIKV infection. Over the same 
period there have been 285 microcephaly cases where ZIKV infection had not previously been 
identified in the mother; congenital Zika syndrome was identified in three of these cases. Our 
findings suggest that should ZIKV continue to circulate endemically, there will be regular 
occurrences of these severe complications and that, in particular, surveillance needs to be able 
to reliably identify and follow up pregnant women.  
 
We do not know why individuals sought care or had their samples sent to the central laboratory 
for processing. In particular, there may be differences by age. If older aged cases were less 
likely to be identified, this would imply even less immunity in the population, whereas reduced 
probability of detection in the youngest individuals would indicate greater immunity. However, 
there were no age-specific guidance for testing so any differences are likely to be minor. 
Further, none of these findings change our inference of long-term circulation of the virus. 
Population-representative seroprevalence studies, with serological assays that can distinguish 
between antibody responses to different flaviviruses (particularly ZIKV, DENV and Japanese 
encephalitis virus) are needed to help quantify the level of circulation and immunity in the 
population.  
 
Our findings provide strong evidence of the long-term and widespread spread of ZIKV in 
Thailand, suggesting that ZIKV is able to transition to endemic transmission. These results 
support the development of long-term sustained interventions and surveillance efforts to tackle 
both the spread of the virus and the regular occurrences of severe ZIKV-related health 
outcomes. 
 
 
 
  
 11 
References 
1 Marchette NJ, Garcia R, Rudnick A. Isolation of Zika virus from Aedes aegypti mosquitoes 
in Malaysia. Am J Trop Med Hyg 1969; 18: 411–5. 
2 Dick GWA, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and serological specificity. 
Trans R Soc Trop Med Hyg 1952; 46: 509–20. 
3 Lessler J, Chaisson LH, Kucirka LM, et al. Assessing the global threat from Zika virus. 
Science 2016; 353: aaf8160. 
4 Cauchemez S, Besnard M, Bompard P, et al. Association between Zika virus and 
microcephaly in French Polynesia, 2013–15: a retrospective study. Lancet 2016; 387: 
2125–32. 
5 Cao-Lormeau V-M, Blake A, Mons S, et al. Guillain-Barré Syndrome outbreak associated 
with Zika virus infection in French Polynesia: a case-control study. Lancet 2016; 387: 1531–
9. 
6 Faria NR, Azevedo R do S da S, Kraemer MUG, et al. Zika virus in the Americas: Early 
epidemiological and genetic findings. Science 2016; 352: 345–9. 
7 Salje H, Cauchemez S, Alera MT, et al. Reconstruction of 60 Years of Chikungunya 
Epidemiology in the Philippines Demonstrates Episodic and Focal Transmission. J Infect 
Dis 2016; 213: 604–10. 
8 Duong V, Dussart P, Buchy P. Zika virus in Asia. Int J Infect Dis 2017; 54: 121–8. 
9 Messina JP, Brady OJ, Scott TW, et al. Global spread of dengue virus types: mapping the 
70 year history. Trends Microbiol 2014; 22: 138–46. 
10 Buathong R, Hermann L, Thaisomboonsuk B, et al. Detection of Zika Virus Infection in 
Thailand, 2012–2014. Am J Trop Med Hyg 2015; 93: 380–3. 
11 Alera MT, Hermann L, Tac-An IA, et al. Zika virus infection, Philippines, 2012. Emerg Infect 
Dis 2015; 21: 722–4. 
12 Nitatpattana N, Chaiyo K, Rajakam S, et al. Complete Genome Sequence of a Zika Virus 
Strain Isolated from the Serum of an Infected Patient in Thailand in 2006. Genome 
Announc 2018; 6. DOI:10.1128/genomeA.00121-18. 
13 Pond WL. ARTHROPOD-BORNE VIRUS ANTIBODIES IN SERA FROM RESIDENTS OF 
SOUTH-EAST ASIA. Trans R Soc Trop Med Hyg 1963; 57: 364–71. 
14 Ho ZJM, Hapuarachchi HC, Barkham T, et al. Outbreak of Zika virus infection in Singapore: 
an epidemiological, entomological, virological, and clinical analysis. Lancet Infect Dis 2017; 
17: 813–21. 
15 Ferguson NM, Cucunubá ZM, Dorigatti I, et al. EPIDEMIOLOGY. Countering the Zika 
epidemic in Latin America. Science 2016; 353: 353–4. 
16 Kraemer MUG, Sinka ME, Duda KA, et al. The global distribution of the arbovirus vectors 
Aedes aegypti and Ae. albopictus. Elife 2015; 4: e08347. 
 12 
17 Rabaa MA, Ty Hang VT, Wills B, Farrar J, Simmons CP, Holmes EC. Phylogeography of 
recently emerged DENV-2 in southern Viet Nam. PLoS Negl Trop Dis 2010; 4: e766. 
18 US Census International Data Base. https://www.census.gov/data-
tools/demo/idb/informationGateway.php (accessed Sept 4, 2018). 
19 Cummings DAT, Iamsirithaworn S, Lessler JT, et al. The impact of the demographic 
transition on dengue in Thailand: insights from a statistical analysis and mathematical 
modeling. PLoS Med 2009; 6: e1000139. 
20 Pacheco O, Beltrán M, Nelson CA, et al. Zika Virus Disease in Colombia - Preliminary 
Report. N Engl J Med 2016; published online June 15. DOI:10.1056/NEJMoa1604037. 
21 Jewell NP, Dufault S, Cutcher Z, Simmons CP, Anders KL. Analysis of cluster-randomized 
test-negative designs: cluster-level methods. Biostatistics 2018; published online Feb 12. 
DOI:10.1093/biostatistics/kxy005. 
22 Salje H, Lessler J, Endy TP, et al. Revealing the microscale spatial signature of dengue 
transmission and immunity in an urban population. Proc Natl Acad Sci U S A 2012; 109: 
9535–8. 
23 Drummond AJ, Suchard MA, Xie D, Rambaut A. Bayesian phylogenetics with BEAUti and 
the BEAST 1.7. Mol Biol Evol 2012; 29: 1969–73. 
24 Salje H, Lessler J, Maljkovic Berry I, et al. Dengue diversity across spatial and temporal 
scales: Local structure and the effect of host population size. Science 2017; 355: 1302–6. 
25 Rodriguez-Barraquer I, Cordeiro MT, Braga C, de Souza WV, Marques ET, Cummings 
DAT. From re-emergence to hyperendemicity: the natural history of the dengue epidemic in 
Brazil. PLoS Negl Trop Dis 2011; 5: e935. 
26 Netto EM, Moreira-Soto A, Pedroso C, et al. High Zika Virus Seroprevalence in Salvador, 
Northeastern Brazil Limits the Potential for Further Outbreaks. MBio 2017; 8. 
DOI:10.1128/mBio.01390-17. 
27 Zambrana JV, Carrillo FB, Burger-Calderon R, et al. Seroprevalence, risk factor, and spatial 
analyses of Zika virus infection after the 2016 epidemic in Managua, Nicaragua. 
Proceedings of the National Academy of Sciences 2018; 115: 9294–9. 
28 Lozier M, Adams L, Febo MF, et al. Incidence of Zika Virus Disease by Age and Sex - 
Puerto Rico, November 1, 2015-October 20, 2016. MMWR Morb Mortal Wkly Rep 2016; 
65: 1219–23. 
29 Thai Ministry of Public Health. Thai. Thai Bureau of Vector Borne Diseases. 
www.thaivbd.org/n/contents/view/325061 (accessed Aug 28, 2018). 
 
 
Contributors: HS conceived the paper, conducted the data analysis and wrote the first draft of 
the manuscript; KR, PW, AP, SS did the underlying data collection, interpretation of the assays 
and contributed to revising the paper; IR-B and DATC contributed to data analysis, data 
interpretation and revising the paper.  
 13 
 
Funding: HS, IR-B and DATC were funded by National Science Foundation (DEB-1642174). 
DATC was also funded by the NIH (R01AI114703).  
 
Conflicts of interest: We declare that we have no conflicts of interest.  
 14 
Figures 
 
Figure 1 
 
 
 
Figure 1. (A) Temporal distribution of the results of testing of symptomatic individuals from 
throughout Thailand 2016-2017. (B) Proportion of symptomatic individuals testing positive in 
each year. (C) Spatial distribution of samples. (D) Proportion of samples testing positive as a 
function of time and type of sample. Each point represent the proportion [positive from a 10-day 
time window. The shaded area represents 95% exact binomial confidence intervals. 
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Figure 2 
 
 
 
Figure 2. Odds of a symptomatic individual testing positive for ZIKV when they live at different 
spatial distances (within district [dark blue], neighbouring district [light blue] and distal district 
[grey]) of a confirmed Zika case sick within different temporal windows relative to the odds of a 
symptomatic individual testing positive for ZIKV anywhere within that same temporal window. 
The box plots represent means with interquartile ranges and 2.5% and 97.5% bootstrapped 
confidence intervals. 
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Figure 3 
 
 
 
Figure 3. Proportion of Zika cases in (A) Thailand and (B) Colombia that are within each age 
group relative to the proportion of the underlying population that are within that age group. (C) 
Proportion of cases of dengue cases in Thailand that are within each age group relative to the 
proportion of the underlying population that are within that age group. The box plots represent 
means with interquartile ranges and 2.5% and 97.5% bootstrapped confidence intervals. 
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Figure 4 
 
 
 
Figure 4. (A) Time-resolved phylogenetic tree of ZIKV sequences available from GenBank. (B) 
Proportion of pairs of sequences isolated within a year of each other that have their Most 
Recent Common Ancestor within different time limits by country of origin for the pair of viruses. 
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Supplementary materials 
 
Table S1 
 
GenBank ID Country Year 
KX197205 Brazil 2015 
KX280026 Brazil 2015 
KX520666 Brazil 2015 
KX830930 Brazil 2016 
KY441403 Brazil 2016 
KY631492 Brazil 2016 
MF073357 Brazil 2016 
MF073358 Brazil 2015 
MF073359 Brazil 2015 
JN860885 Cambodia 2010 
KU955593 Cambodia 2010 
MH158236 Cambodia 2010 
KU820897 Colombia 2015 
KY317938 Colombia 2016 
KY317939 Colombia 2016 
KY317940 Colombia 2016 
KY989971 Colombia 2015 
KX447510 FrenchPolynesia 2013 
KX447511 FrenchPolynesia 2014 
KX447514 FrenchPolynesia 2014 
KX447515 FrenchPolynesia 2013 
KX447517 FrenchPolynesia 2014 
KU179098 Indonesia 2014 
KX377336 Malaysia 1966 
KX694533 Malaysia 1966 
KU681082 Philippines 2012 
KY241671 Singapore 2016 
KY241684 Singapore 2016 
MF988734 Singapore 2017 
KU681081 Thailand 2014 
KX051560 Thailand 2013 
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KX051561 Thailand 2013 
KX051562 Thailand 2015 
KX694532 Thailand 2013 
KY272987 Thailand 2016 
MG645981 Thailand 2006 
MH119185 Thailand 2016 
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Figure S1 
 
 
 
Figure S1. (A) Probability of testing positive for individuals from provinces in the South (S), 
North (N), West (W), East (E), Central (C) and Northeast (NE) of the country relative to the 
probability of testing positive anywhere. (B) Location of the different regions.  
 
 
